Sep 06, 2022 4:05pm EDT Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference
Jun 13, 2022 8:00am EDT Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients
Feb 17, 2022 8:00am EST Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
